A new chronic model of spontaneous nonconvulsive generalized seizures.
Ono
K
K
Department of Physiology, Nagasaki University School of Medicine.
Baba
H
H
Sugai
S
S
D015107:4-Butyrolactone / Q000494:pharmacology*; D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects / Q000503:physiopathology; D003337:Corpus Callosum / Q000187:drug effects / Q000503:physiopathology; D004569:Electroencephalography / Q000187:drug effects; D004832:Epilepsy, Absence / Q000139:chemically induced* / Q000503:physiopathology; D004829:Epilepsy, Generalized / Q000139:chemically induced* / Q000503:physiopathology; D005013:Ethosuximide / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D007274:Injections, Intraperitoneal; D008297:Male; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology; D012978:Sodium Oxybate / Q000494:pharmacology*; D014635:Valproic Acid / Q000494:pharmacology
D005013:Ethosuximide; D014635:Valproic Acid; D010672:Phenytoin; D012978:Sodium Oxybate; D015107:4-Butyrolactone